Arquer Diagnostics: New head for Dx
Diagnostics company Arquer Diagnostics Ltd (Sunderland, UK) has appointed Nadia Whittley as CEO, replacing Ian Campbell with immediate effect. Whittley will be responsible for launching the companys MCM5-ELISA diagnostic test and the expanding the technology beyond bladder and prostate cancer.
Before joining Arquer Diagnostics, Whittley was Partner and Managing Director, Europe, of Tefen Management Consulting, where she was responsible for the design and implementation of a 5-year strategic plan and development of the Life Science Business Unit in EMEA. Previously, she was CEO at Alium Medical Ltd, Managing Director Medical Devices EAME at Allergan Inc., Marketing Director EMEA in Interventional Cardiology at Boston Scientific International, and a non-executive Board member at Peptonic Medical AB.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium